Investors Grab ALLO Even Cheaper Than Its Secondary Stock Offering
May 17, 2024 at 13:18 PM EDT
Looking back to 4 days ago, Allogene Therapeutics Inc (ALLO) priced a 37,931,035 share secondary stock offering at $2.90 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..